Breaking News, Financial News

Financial Report: WuXi PharmaTech

Revenues climb 22% in 2011

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

WuXi PharmaTech 4Q Revenues: $108.5 million (+23%) 4Q Earnings: $23.5 million (+36%) FY Revenues: $407.2 million (+22%) FY Earnings: $81.0 million (+11%) Comments: In the quarter manufacturing revenues were $15.7 million (+56%) and for year were $75.2 million (+92%). Laboratory services revenue was $92.8 million in the quarter (+18%) and $332.0 million for the year (+13%). China-based lab services accounted for $72.0 million in the quarter, up 21%, and $251.7 million for the year, up 15%. U...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters